Julie Rosenberg, MD
Julie Rosenberg, MD, is an experienced life sciences leader with a proven track record of success in leading global drug development and pharmacovigilance programs. As a highly skilled pediatric hematologist-oncologist and accomplished business leader, she partners with biopharma companies—from startups to established enterprises—to solve complex challenges in clinical development, trial design, operational efficiency and regulatory strategy.
Dr. Rosenberg provides high-level strategic oversight as well as a wealth of on-the-ground expertise in areas such as medical monitoring, data review, protocol development, and drafting clinical study reports. She frequently leverages her deep insight to support company interactions with global regulatory authorities, including the FDA and EMA. Her ability to balance high-level strategic vision with tactical execution makes her an invaluable asset to any biopharma team.
Recognized for her leadership and impact, Dr. Rosenberg is an invited member of both the Marshall Goldsmith ‘MG’ 100—a select group of top consultants, coaches, and entrepreneurs— and the International Women’s Forum, a global organization of influential female leaders dedicated to driving progress and change.